No problem Monet anytime. I am not clear on the reporting requirements for these maladies like STC. Maybe providers have a couple years to send in the data to the government for diagnosis and procedures they perform so that not all the data has been reported yet. We are almost at the end of the year so I would think a fairly large percentage of the data has already been reported (say 80%), and I doubt there would be much change for the remaing 20% of data to be reported. So right now we know that there has been a 33% increase in the STC case rate since 2018 (3 versus 4 for the U.S. STC case rate) which is definitely significant.
So one scenario then is that Yeadon's hypothesis regarding this is correct and it will take a 2 or 3 years for the STCs to start to develop in people who got vaccinated and so 2024 might be when the large increases start to get observed.
Another scenario which is not mutually exclusive to the latency scenario above is that STCs are currently being under-reported because people are not able to get in to see providers to get a diagnosis even though they might already have developed tumors.
What would be really interesting would be to stratify the chart posted above for vaccinated versus unvaccinated such that you have 4 lines on the graph rather than 2 lines: U.S. STC death rates and case rates for vaccinated individuals and U.S. STC death rates and case rates for unvaccinated individuals (for each year). But vaccinated information might not have been sent in or may be incomplete so that such a stratification can't yet be produced.